Results 81 to 90 of about 908,314 (313)

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Satoshi Ito Oral History Interview, June 30, 2009 [PDF]

open access: yes, 2009
The interview of Prof. Satoshi Ito was conducted by Amy Schindler, University Archivist in the Special Collections Research Center in the Earl Gregg Swem Library at the College of William and Mary, on June 30, 2009.Found In: UA 43, University Archives ...
Schindler, Amy C., Ito, Satoshi
core  

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Developing tissue engineered models of oral mucosa and oral cancer to study novel therapeutic and diagnostic techniques. [PDF]

open access: yes, 2010
In the UK in 2008 over 1,800 people died from oral cancer. Despite advances in surgery and therapy the survival rates for those diagnosed with oral cancer have not significantly improved over the past 20 years.
Hearnden, Vanessa
core  

Safety, pharmacokinetic, and efficacy studies of oral DB868 in a first stage vervet monkey model of human African trypanosomiasis [PDF]

open access: yes, 2013
There are no oral drugs for human African trypanosomiasis (HAT, sleeping sickness). A successful oral drug would have the potential to reduce or eliminate the need for patient hospitalization, thus reducing healthcare costs of HAT.
Arlene S. Bridges (301008)   +65 more
core   +1 more source

Parenteral systems for statin delivery: a review

open access: yesLipids in Health and Disease, 2019
The oral route of drug administration is the most common and convenient route for dosing statin drugs, and, in fact, most medications, because of ease of drug delivery, patient compliance, and cost-effectiveness.
Shahla Korani   +5 more
doaj   +1 more source

The difficulties experienced during the preparation and administration of oral drugs by parents at home: a cross-sectional study from Palestine

open access: yesBMC Pediatrics, 2020
Background Failure to properly administer drugs to children at home may cause adverse events, which makes it a challenging job for parents or caregivers.
Ra’fat Ali   +3 more
doaj   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

open access: yesMolecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach   +9 more
wiley   +1 more source

Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease [PDF]

open access: yes, 2001
Dose-finding studies and trials of interaction of oral glycoprotein IIb/IIIa antagonists with other antiplatelet agents have been limited. We hypothesized that these detailed assessments could be first performed in patients with stable coronary artery ...
Rocca, Bianca
core  

Oral rush desensitization in peanut allergy: a case report [PDF]

open access: yes, 2006
Oral rush desensitization in peanut allergy: a case ...
Roncallo, Chiara   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy